B-natriuretic peptide (BNP) and its N terminal segment (NT-proBNP) are clinically available tests which have been well-established to be elevated in patients with congestive heart failure of multiple etiologies, but also in PH generally and in SSc-PAH. The gene discussed is NPPB; the disease is systemic sclerosis.